Cue Health (Nasdaq: HLTH) is a healthcare technology company that puts consumers in control of their health information and places diagnostic information at the center of care.
Cue Health enables people to manage their health through real-time, actionable, and connected health information, offering individuals and their healthcare providers easy access to lab-quality diagnostics anywhere, anytime, in a device that fits in the palm of the hand. Cue Health’s first-of-its-kind COVID-19 test was the first FDA-authorized molecular diagnostic test for at-home and over-the-counter use without a prescription and physician supervision.
Outside the United States, Cue Health has received the CE mark in the European Union, Interim Order authorization from Health Canada, and regulatory approval from India’s Central Drugs Standard Control Organisation.
Cue was founded in 2010 and is headquartered in San Diego. For more information, please visit www.cuehealth.com.
Authorized to be used in professional point-of-care settings, the nucleic acid amplification test can detect mpox virus and deliver results in 25 minutes SAN DIEGO--(BUSINESS WIRE)--Mar. 20, 2023-- Cue Health (“Cue”) (Nasdaq: HLTH), a healthca...
SAN DIEGO--(BUSINESS WIRE)--Mar. 15, 2023-- Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the fourth quarter and full-year 2022. Recent and Full-Year 2022 Highlights Report...
Cue Health’s New Suite of At-Home Diagnostic Tests and Expansion of Cue Care Puts You in Control of Your Health
Mar 13, 2023
Get actionable health information and convenient access to treatment for a wide range of general health & wellness conditions, including sexual, heart, and metabolic health SAN DIEGO--(BUSINESS WIRE)--Mar. 13, 2023-- Cue Health (“Cue”...